Phase II study of 5-aza-2′-deoxycytidine (decitabine) in patients (pts) with Philadelphia (Ph) chromosome positive chronic myelogenous leukemia (CML) resistant or intolerant to imatinib mesylate.
被引:0
作者:
Issa, JP
论文数: 0引用数: 0
h-index: 0
机构:
MD Anderson Canc Ctr, Dept Leukemia, Houston, TX USAMD Anderson Canc Ctr, Dept Leukemia, Houston, TX USA
Issa, JP
[1
]
Garcia-Manero, G
论文数: 0引用数: 0
h-index: 0
机构:
MD Anderson Canc Ctr, Dept Leukemia, Houston, TX USAMD Anderson Canc Ctr, Dept Leukemia, Houston, TX USA
Garcia-Manero, G
[1
]
Talpaz, M
论文数: 0引用数: 0
h-index: 0
机构:
MD Anderson Canc Ctr, Dept Leukemia, Houston, TX USAMD Anderson Canc Ctr, Dept Leukemia, Houston, TX USA
Talpaz, M
[1
]
Cortes, J
论文数: 0引用数: 0
h-index: 0
机构:
MD Anderson Canc Ctr, Dept Leukemia, Houston, TX USAMD Anderson Canc Ctr, Dept Leukemia, Houston, TX USA
Cortes, J
[1
]
Giles, F
论文数: 0引用数: 0
h-index: 0
机构:
MD Anderson Canc Ctr, Dept Leukemia, Houston, TX USAMD Anderson Canc Ctr, Dept Leukemia, Houston, TX USA
Giles, F
[1
]
Vestovsek, S
论文数: 0引用数: 0
h-index: 0
机构:
MD Anderson Canc Ctr, Dept Leukemia, Houston, TX USAMD Anderson Canc Ctr, Dept Leukemia, Houston, TX USA
Vestovsek, S
[1
]
Faderl, S
论文数: 0引用数: 0
h-index: 0
机构:
MD Anderson Canc Ctr, Dept Leukemia, Houston, TX USAMD Anderson Canc Ctr, Dept Leukemia, Houston, TX USA
Faderl, S
[1
]
O'Brien, S
论文数: 0引用数: 0
h-index: 0
机构:
MD Anderson Canc Ctr, Dept Leukemia, Houston, TX USAMD Anderson Canc Ctr, Dept Leukemia, Houston, TX USA
O'Brien, S
[1
]
Morris, G
论文数: 0引用数: 0
h-index: 0
机构:
MD Anderson Canc Ctr, Dept Leukemia, Houston, TX USAMD Anderson Canc Ctr, Dept Leukemia, Houston, TX USA
Morris, G
[1
]
Kantarjian, H
论文数: 0引用数: 0
h-index: 0
机构:
MD Anderson Canc Ctr, Dept Leukemia, Houston, TX USAMD Anderson Canc Ctr, Dept Leukemia, Houston, TX USA
Kantarjian, H
[1
]
机构:
[1] MD Anderson Canc Ctr, Dept Leukemia, Houston, TX USA